Skip to main content
Erschienen in: Virchows Archiv 3/2014

01.09.2014 | Original Article

Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome

verfasst von: Meijing Ren, Fangfang Liu, Yufen Zhu, Yaqing Li, Ronggang Lang, Yu Fan, Feng Gu, Xinmin Zhang, Li Fu

Erschienen in: Virchows Archiv | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Caveolin-1 (Cav-1) expression in stromal carcinoma-associated fibroblasts (CAFs) has been associated with tumor progression and clinical outcome. This study was undertaken to assess its prognostic significance in invasive micropapillary carcinoma of the breast (IMPC), a tumor with abundant stromal CAFs and a high tendency for nodal metastasis and poor outcome. Cav-1 expression was studied by immunohistochemistry in a group of 86 cases of IMPC along with a control group of 105 cases of invasive ductal carcinoma, not otherwise specified (IDC-NOS). Our results indicate that absence of Cav-1 expression in CAFs of IMPC is more common than in IDC-NOS (57 %, 49/86 vs. 36 %, 38/105). The absence of expression was associated with larger tumor size and higher lymph node stage (P < 0.05) of IMPC. Univariate analysis suggested absence of Cav-1 in CAFs to be a candidate independent predictor of reduced progression-free survival (PFS) (HR = 3.945, 95 % CI = 1.717–9.063, P = 0.001), which was confirmed by multivariable analysis (P = 0.018). In patients with IMPC spreading to local lymph nodes, loss of stromal Cav-1 predicted a fourfold increase in risk for shortened PFS. In contrast, no significant difference of tumor epithelial Cav-1 expression was found between IMPC and IDC-NOS, and the expression of tumor Cav-1 was not significantly associated with the prognosis of patients with IMPC. Absence of Cav-1 expression in CAFs is a strong prognostic factor for IMPC patients, and it may further subgroup the patients with lymph node metastasis to guide clinical management.
Literatur
1.
Zurück zum Zitat Schauer IG, Sood AK, Mok S et al (2011) Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer. Neoplasia 13:393–405PubMedCentralPubMed Schauer IG, Sood AK, Mok S et al (2011) Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer. Neoplasia 13:393–405PubMedCentralPubMed
2.
Zurück zum Zitat Xing F, Saidou J, Watabe K (2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci 15:166–179CrossRef Xing F, Saidou J, Watabe K (2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci 15:166–179CrossRef
3.
Zurück zum Zitat Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB et al (2010) Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 9:3256–3276PubMedCentralPubMed Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB et al (2010) Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 9:3256–3276PubMedCentralPubMed
4.
Zurück zum Zitat Guido C, Whitaker-Menezes D, Capparelli C et al (2012) Metabolic reprogramming of cancer-associated fibroblasts by TGF-beta drives tumor growth: connecting TGF-beta signaling with "Warburg-like" cancer metabolism and L-lactate production. Cell Cycle 11:3019–3035PubMedCentralPubMedCrossRef Guido C, Whitaker-Menezes D, Capparelli C et al (2012) Metabolic reprogramming of cancer-associated fibroblasts by TGF-beta drives tumor growth: connecting TGF-beta signaling with "Warburg-like" cancer metabolism and L-lactate production. Cell Cycle 11:3019–3035PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Pavlides S, Tsirigos A, Vera I et al (2010) Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation. Cell Cycle 9:2201–2219PubMedCrossRef Pavlides S, Tsirigos A, Vera I et al (2010) Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation. Cell Cycle 9:2201–2219PubMedCrossRef
6.
Zurück zum Zitat Sotgia F, Martinez-Outschoorn UE, Howell A et al (2012) Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annu Rev Pathol 7:423–467PubMedCrossRef Sotgia F, Martinez-Outschoorn UE, Howell A et al (2012) Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annu Rev Pathol 7:423–467PubMedCrossRef
7.
Zurück zum Zitat Park SS, Kim JE, Kim YA et al (2005) Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast. Histopathology 47:625–630PubMedCrossRef Park SS, Kim JE, Kim YA et al (2005) Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast. Histopathology 47:625–630PubMedCrossRef
8.
Zurück zum Zitat Mercier I, Casimiro MC, Wang C et al (2008) Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy. Cancer Biol Ther 7:1212–1225PubMedCrossRef Mercier I, Casimiro MC, Wang C et al (2008) Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy. Cancer Biol Ther 7:1212–1225PubMedCrossRef
9.
10.
Zurück zum Zitat Witkiewicz AK, Dasgupta A, Sotgia F et al (2009) An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 174:2023–2034PubMedCentralPubMedCrossRef Witkiewicz AK, Dasgupta A, Sotgia F et al (2009) An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 174:2023–2034PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Witkiewicz AK, Dasgupta A, Sammons S et al (2010) Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers. Cancer Biol Ther 10:135–143PubMedCentralPubMedCrossRef Witkiewicz AK, Dasgupta A, Sammons S et al (2010) Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers. Cancer Biol Ther 10:135–143PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat El-Gendi SM, Mostafa MF, El-Gendi AM (2012) Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome. Pathol Oncol Res 18:459–469PubMedCrossRef El-Gendi SM, Mostafa MF, El-Gendi AM (2012) Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome. Pathol Oncol Res 18:459–469PubMedCrossRef
13.
Zurück zum Zitat Simpkins SA, Hanby AM, Holliday DL et al (2012) Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts. J Pathol 227:490–498PubMedCrossRef Simpkins SA, Hanby AM, Holliday DL et al (2012) Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts. J Pathol 227:490–498PubMedCrossRef
14.
Zurück zum Zitat Zekioglu O, Erhan Y, Ciris M et al (2004) Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology 44:18–23PubMedCrossRef Zekioglu O, Erhan Y, Ciris M et al (2004) Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology 44:18–23PubMedCrossRef
15.
Zurück zum Zitat Walsh MM, Bleiweiss IJ (2001) Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol 32:583–589PubMedCrossRef Walsh MM, Bleiweiss IJ (2001) Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol 32:583–589PubMedCrossRef
16.
Zurück zum Zitat Fu L, Ikuo M, Fu XY et al (2004) Relationship between biologic behavior and morphologic features of invasive micropapillary carcinoma of the breast. Zhonghua Bing Li Xue Za Zhi 33:21–25PubMed Fu L, Ikuo M, Fu XY et al (2004) Relationship between biologic behavior and morphologic features of invasive micropapillary carcinoma of the breast. Zhonghua Bing Li Xue Za Zhi 33:21–25PubMed
17.
Zurück zum Zitat Reis-Filho JS, Ellis IO (2012) WHO classification of tumours of the breast. IARC, Lyon Reis-Filho JS, Ellis IO (2012) WHO classification of tumours of the breast. IARC, Lyon
18.
Zurück zum Zitat Hammond ME, Hayes DF, Dowsett M et al (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784–2795PubMedCentralPubMedCrossRef Hammond ME, Hayes DF, Dowsett M et al (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784–2795PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Cantiani L, Manara MC, Zucchini C et al (2007) Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling. Cancer Res 67:7675–7685PubMedCrossRef Cantiani L, Manara MC, Zucchini C et al (2007) Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling. Cancer Res 67:7675–7685PubMedCrossRef
20.
Zurück zum Zitat Wikman H, Kettunen E, Seppanen JK et al (2002) Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21:5804–5813PubMedCrossRef Wikman H, Kettunen E, Seppanen JK et al (2002) Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21:5804–5813PubMedCrossRef
21.
Zurück zum Zitat Kato K, Hida Y, Miyamoto M et al (2002) Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94:929–933PubMedCrossRef Kato K, Hida Y, Miyamoto M et al (2002) Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94:929–933PubMedCrossRef
22.
Zurück zum Zitat Nam KH, Lee BL, Park JH et al (2013) Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer. Pathobiology 80:87–94PubMedCrossRef Nam KH, Lee BL, Park JH et al (2013) Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer. Pathobiology 80:87–94PubMedCrossRef
23.
Zurück zum Zitat Liu P, Rudick M, Anderson RG (2002) Multiple functions of caveolin-1. J Biol Chem 277:41295–41298PubMedCrossRef Liu P, Rudick M, Anderson RG (2002) Multiple functions of caveolin-1. J Biol Chem 277:41295–41298PubMedCrossRef
24.
Zurück zum Zitat Liu F, Lang R, Wei J et al (2009) Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Histopathology 54:741–750PubMedCrossRef Liu F, Lang R, Wei J et al (2009) Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Histopathology 54:741–750PubMedCrossRef
25.
Zurück zum Zitat Li W, Liu F, Lei T et al (2010) The clinicopathological significance of CD44+/CD24−/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast. Pathol Res Pract 206:828–834PubMedCrossRef Li W, Liu F, Lei T et al (2010) The clinicopathological significance of CD44+/CD24−/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast. Pathol Res Pract 206:828–834PubMedCrossRef
26.
Zurück zum Zitat Elsheikh SE, Green AR, Rakha EA et al (2008) Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br J Cancer 99:327–334PubMedCentralPubMedCrossRef Elsheikh SE, Green AR, Rakha EA et al (2008) Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br J Cancer 99:327–334PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Li T, Sotgia F, Vuolo MA et al (2006) Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. Am J Pathol 168:1998–2013PubMedCentralPubMedCrossRef Li T, Sotgia F, Vuolo MA et al (2006) Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. Am J Pathol 168:1998–2013PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Di Vizio D, Morello M, Sotgia F et al (2009) An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle 8:2420–2424PubMedCentralPubMedCrossRef Di Vizio D, Morello M, Sotgia F et al (2009) An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle 8:2420–2424PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Jia Y, Wang N, Wang J et al (2014) Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis. Ann Surg Oncol 21:329–336PubMedCrossRef Jia Y, Wang N, Wang J et al (2014) Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis. Ann Surg Oncol 21:329–336PubMedCrossRef
30.
Zurück zum Zitat Pavlides S, Tsirigos A, Migneco G et al (2010) The autophagic tumor stroma model of cancer: role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 9:3485–3505PubMedCentralPubMedCrossRef Pavlides S, Tsirigos A, Migneco G et al (2010) The autophagic tumor stroma model of cancer: role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 9:3485–3505PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Salem AF, Whitaker-Menezes D, Lin Z et al (2012) Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells. Cell Cycle 11:2545–2556PubMedCentralPubMedCrossRef Salem AF, Whitaker-Menezes D, Lin Z et al (2012) Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells. Cell Cycle 11:2545–2556PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Sotgia F, Martinez-Outschoorn UE, Pavlides S et al (2011) Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Res 13:213PubMedCentralPubMedCrossRef Sotgia F, Martinez-Outschoorn UE, Pavlides S et al (2011) Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Res 13:213PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Sanchez-Alvarez R, Martinez-Outschoorn UE, Lin Z et al (2013) Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention. Cell Cycle 12:289–301PubMedCentralPubMedCrossRef Sanchez-Alvarez R, Martinez-Outschoorn UE, Lin Z et al (2013) Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention. Cell Cycle 12:289–301PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Senetta R, Stella G, Pozzi E et al (2013) Caveolin-1 as a promoter of tumour spreading: when, how, where and why. J Cell Mol Med 17:325–336PubMedCrossRef Senetta R, Stella G, Pozzi E et al (2013) Caveolin-1 as a promoter of tumour spreading: when, how, where and why. J Cell Mol Med 17:325–336PubMedCrossRef
35.
Zurück zum Zitat Goetz JG, Minguet S, Navarro-Lerida I et al (2011) Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 146:148–163PubMedCentralPubMedCrossRef Goetz JG, Minguet S, Navarro-Lerida I et al (2011) Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 146:148–163PubMedCentralPubMedCrossRef
36.
Zurück zum Zitat Ayala G, Morello M, Frolov A et al (2013) Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression. J Pathol 231:77–87PubMedCentralPubMedCrossRef Ayala G, Morello M, Frolov A et al (2013) Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression. J Pathol 231:77–87PubMedCentralPubMedCrossRef
37.
38.
Zurück zum Zitat Bodmer M, Meier C, Krahenbuhl S et al (2010) Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 33:1304–1308PubMedCentralPubMedCrossRef Bodmer M, Meier C, Krahenbuhl S et al (2010) Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 33:1304–1308PubMedCentralPubMedCrossRef
Metadaten
Titel
Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome
verfasst von
Meijing Ren
Fangfang Liu
Yufen Zhu
Yaqing Li
Ronggang Lang
Yu Fan
Feng Gu
Xinmin Zhang
Li Fu
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 3/2014
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-014-1614-6

Weitere Artikel der Ausgabe 3/2014

Virchows Archiv 3/2014 Zur Ausgabe

Neu im Fachgebiet Pathologie